Agouron Pharmaceuticals, Inc.’s operations consists of the discovery, development, manufacture, and marketing of therapeutic products engineered to inactivate proteins, which play roles in cancer, AIDS, and other serious diseases. Its product, VIRACEPT®, was a drug for the treatment of HIV infection. Agouron Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

MicroMedMark develops basic research, applied basic research, transformation research, and a biomedical technology enterprise for industrial transformation. Their products and services include a pancreatic cancer detection kit, a detection kit product pipeline, and nucleic acid.

Beijing Lifecode Biotechnology Co., Ltd., established on 2009-07-23, The scope of business includes the sale of food;biotechnology development,technical consulting,technology transfer,Technical Services;Import and export;Agent import and export;Technology Import and Export;Enterprise Management Services;Health Advisory(Except for medical treatment activities subject to approval);Technical testing.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

The Nanjing General Hospital of People's Liberation Army (NGH; Chinese: 中国人民解放军南京总医院), formerly Nanjing General Hospital of Nanjing Military Command (Chinese: 中国人民解放军南京军区南京总医院), or Nanjing General Hospital, The Military General Hospital, is also known as Jinling Hospital (formally Jinling Hospital of the Medical School of Nanjing University) which used to be Central Hospital. NGH is located at 305 Zhongshan East Road, Nanjing, Jiangsu Province, China. It is a large comprehensive teaching hospital integrating medical services with teaching and research.

Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Shanghai Cluster Biotechnology Co., Ltd., established on 2009-04-02, Business scope includes technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer;Chemical reagents and chemical products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)to develop,Sales;Computer hardware and software and consumables(In addition to special products for computer information system security)Sales;Conference and exhibition services;Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Guangzhou Institutes of Biomedicine and Health (GIBH)，(simplified Chinese: 中国科学院广州生物医药与健康研究院; traditional Chinese: 中國科學院廣州生物醫藥與健康研究院; pinyin: Zhōngguó Kēxué yuan guangzhou sheng wu yi yao yu jian kang yan jiu yuan) affiliated with the Chinese Academy of Sciences, is a government-sponsored scientific research institution with independent legal jurisdiction. GIBH was established by the Chinese Academy of Sciences, Guangdong Provincial Government and Guangzhou Municipal Government. The managerial mechanism of GIBH is the responsibility of Director-General, under the authority of the board of trustees.

Shangqiu Cancer Institute, established on 1997-08-01, Business scope includes biotechnology development.Development of new drugs for preventing and treating tumors.to promote.application.Production.Sales.***

Shenji Bio focuses on the research and development of fundamental raw materials such as nucleosides, nucleotides, diagnostic antigens, and antibodies. As a development direction, Shenji Bio provides cost-effective products and addresses clinical unmet needs. It has gradually entered the upstream core raw material fields of IVD, mRNA, CGT, and other industries, and has established a high-quality key common technology platform to provide overall solutions for the life science field's development.

Boehringer Ingelheim Vetmedica GmbH, part of C.H. Boehringer Sohn AG & Co. KG, is a German company located in Ingelheim am Rhein that manufactures and sells animal vaccines and pharmaceuticals. Stephan Günther Dolle and Dana Leskova are the current co-CEOs of the firm.

Shenzhen Mingma Biological Detection Co., Ltd., established on 2018-03-20, Business scope includes general business items:Business Management Consulting,Class I medical device,Sales of Class II Medical Devices,Wholesale of Class III Medical Devices(See license for scope).[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments];Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based materials technology;Health Consulting Services(Does not include medical services);Sales of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Production of the third category of non-pharmaceutical precursor chemicals;Production of Class I Medical Devices;Class III medical device business;Sales of Class II Medical Devices;food sales;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shenzhen Pulilang Biotechnology Co., Ltd., established on 2012-05-11, Business scope includes general business items:Invest in business(Specific projects will be reported separately);Investment Advisory(No restricted items);Operating e-commerce;Internet business service,database service,database management;Domestic Trade(Does not contain franchise,monopoly,Specially Controlled Commodities);Operating import and export business;Primary Agricultural Sales;clothing,textile,knitwear,General merchandise sales;stationery,Sporting Goods Sales;Building materials sales;Equipment,hardware products,electronics sales;jewelry,crafts(Does not contain ivory and its products)Sales;cosmetic,sales of hygiene products;Chemical Products,Polymer Materials,R&D and sales of fiber materials, processes and equipment;Printed circuit board design and sales;Technical development of protective materials;coating,Sales of fireproof materials;Sales of Class I medical supplies and equipment;computer,Sales of software and auxiliary equipment;Instrumentation,Sales of office equipment;computer software,Technical development of information system software,Sales;Information system design,integrated,Operation and Maintenance;Information Technology Consulting;IC Design,research and development;Machinery and Equipment Leasing(Leasing of machinery and equipment without operators,Excluding financial leasing activities);Car rental(Does not include car rental with operator);Agricultural Machinery Rental;Construction machinery and equipment rental;Computer and communication equipment rental;bike,Photographic Equipment Rental;Sports Equipment Rental;Economic Information Consulting(No restricted items);Business Management Consulting(No restricted items);Business Consulting;Business information consultation;Agricultural Technology,Biotechnology,new material technology,Energy saving technology development;Technical development of biological products;Technology development of biotechnology products;Science and Technology Information Consulting.,The licensing program is:Laboratory Biological Reagents,Sales of consumables;Leasing of medical equipment.

Nanjing Hanwei Public Health Research Institute Co., Ltd., established on 2020-08-19, Business scope includes general items:Medical Research and Experimental Development;Artificial intelligence public service platform technical consulting services;IoT application service;Artificial intelligence application software development;software development;Information system integration service;internet data service;Data processing and storage support services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Environmental Protection Monitoring;business management;Engineering Management Services;Health Consulting Services(Does not include medical services);Socioeconomic Advisory Services;Instrument sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Nanjing Bona Tianyuan Biotechnology Co., Ltd., established on 2013-03-20, Business scope includes research and development of biological products;Electronic product development,Sales;software development;Computer Product Sales and Repair;Computer network engineering installation;Research and development of computer network technology,transfer,training(Does not include training or services related to academic education),Consulting and Technical Services;Security equipment installation,Commissioning and Sales;audio,Installation of video equipment,commissioning and sales;Intelligent engineering construction,design;e-commerce;Information Consulting Service;Sales of building materials;Research and development of environmental protection equipment,Production,Sales,Install,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Guangzhou Medical University New Drug Creation Co., Ltd., established on 2015-08-21, Business scope includes medical research and experimental development;Biomedical Technology Research;Biotechnology Development Services;Biotechnology Transfer Services;drug development;Stem Cell Drug Development;Stem Cell Technology Research,to develop;Health Sciences Program Research Transfer;Technology intermediary service;Biological Products Testing;Clinical Laboratory Services;Manufacturing of chemical raw materials

Bioneer is a Danish advanced technology company, providing custom development- and analytical services to projects in drug development- and diagnostic companies, academic groups and hospitals. Bioneer is highly specialized within applications of cells, using their extensive knowledge anywhere from disease modeling using pluripotent stem cells and human primary cells; to recombinant protein production and biomarker identification/validation (RNA, DNA, protein) in single-cell- and tissue preparations. Furthermore, Bioneer also offers drug development of small molecules and biologics, from characterization through to a final formulation.